Explore ViiV Healthcare

amfAR TREAT Asia

Photo courtesy of Kevin Tachman/TREAT Asia

The project

In 2010 we set out on a multi-year collaboration with ViiV Healthcare’s Paediatric Innovation Seed Fund to address critical gaps in HIV/AIDS research, care and treatment programmes for infants, children and adolescents in the region. Through integrated programmes in research, provider education and global advocacy, we work to fill these gaps in order to optimise treatment for paediatric populations and develop effective long-term strategies for high-quality care. 

Key Facts

Project: A multi-year partnership designed to optimise the quality of healthcare for infants, children and adolescents living with HIV across Asia.

Run by: TREAT Asia/amfAR

Region: Asia-Pacific

Population: Infants, children and adolescents living with HIV

Challenges: High first-line antiretroviral therapy (ART) failure rates among children; Limited availability of ART regimens that can be dosed and delivered to newborns and young children, and that are safe to use during growth and development; Poor access to once-daily fixed-dose combination medicines and third-line options for adolescents; Gaps in research capacity and higher-level training for paediatric HIV providers.

Activities: Conducting integrated and innovative programmes in research, provider education and global advocacy, with a focus on treatment failure, the emergence of drug-resistance and optimising antiretroviral sequencing for children living with HIV, among other important considerations for paediatric populations in the region and across the globe. 

Gallery